Delivery Order SPE2DB24D3013-SPE2DB25FFLZV

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication. The delivery order has a ceiling value of $3,790.86 and a completion date of May 22, 2025. The contract is a firm fixed-price, non-set-aside vehicle, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,504.50, is for the delivery of the diabetes medication Trulicity (3 mg/0.5 mL pen, 0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with a performance period through May 2, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity 0.75 mg/0.5 ml pen. The contract has a firm fixed price, ceiling value of $5,577.05, and a period of performance through May 13, 2025. The contract is not set aside and is a standard open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity (0.75 mg/0.5 ml pens). The contract has a ceiling value of $27,576.60 and a period of performance through October 30, 2024. It was awarded on October 29, 2020 as a firm fixed-price contract with no set-aside requirements. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication, with a ceiling value of $4,567.79 and a performance period through May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a firm fixed price of $3,055.56 and a performance period through May 13, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen, a medication used to treat diabetes. The contract has a ceiling value of $2,902.99 and a period of performance through April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Trulicity 1.5 mg/0.5 ml pen. The contract has a ceiling value of $5,556.96 and a period of performance through May 30, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,139.37, is for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. It is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $13,013.30 and a performance period through April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFLZV
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the diabetes medication Trulicity (0.75 mg/0.5 ml pen, 0.5 ml). The contract has a ceiling value of $4,266.97 and a period of performance through May 28, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies through December 2026.

Generated 8/31/25, 1:08 AM